Raunaq Laboratories Ltd
About Raunaq Laboratories Ltd
Data last updated:
Raunaq Laboratories Ltd is a public limited company based in Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 January 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U99999PB1994PLC014099. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Binti Bijaysingh Thakur and Anil Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wg 554/1 Sony Nagarnakodar Road Jalandhar, Punjab, India.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.86 Cr. For the same year it recorded a net profit of ₹44,813 (net margin 0.2%) and EBITDA of ₹51,754 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 292% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Raunaq Laboratories has one previous CIN (Corporate Identification Number): L99999PB1994PLC014099. The current CIN is U99999PB1994PLC014099, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999PB1994PLC014099 | Current |
| L99999PB1994PLC014099 | Previous |
Contact details
Raunaq Laboratories Ltd's registered office is in Punjab. Its e-mail address is in the company report.
- Email
- Registered AddressWg 554/1 Sony Nagarnakodar Road Jalandhar, Punjab, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Raunaq Laboratories Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raunaq Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Raunaq Laboratories Ltd
FY 2025 filings availableRaunaq Laboratories Ltd reported revenue of ₹1.86 Cr for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 292% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.86 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51,754 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44,813 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raunaq Laboratories Ltd, buy the company report.
Board of directors of Raunaq Laboratories Ltd
Raunaq Laboratories has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Binti Bijaysingh Thakur | Director | 27 May 2002 | 24 Years 4 Months | Current |
| Anil Kumar Jain | Director | 01 Sep 2005 | 21 Years 1 Months | Current |
| Jay Kothari Also directs: Panjon Limited | Director | 21 Apr 2017 | 9 Years 6 Months | Current |
Auditor
Raunaq Laboratories Ltd is audited by M/s MANISH KADWANE & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s MANISH KADWANE & CO. | FY 2022 | 010496C |
Shareholding
The shareholding of Raunaq Laboratories Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Raunaq Laboratories Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Raunaq Laboratories Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raunaq Laboratories Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raunaq Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Raunaq Laboratories Ltd, buy the company report.
Recent activity
Raunaq Laboratories Ltd has 5 board changes on record since 2002: 3 appointments and 2 cessations. The latest: Jay Kothari ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Raunaq Laboratories is an active public limited company based in Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 January 1994 (32+ years old) and is registered under CIN U99999PB1994PLC014099.
Raunaq Laboratories has 3 current directors:
- Binti Bijaysingh Thakur - Director
- Anil Kumar Jain - Director
- Jay Kothari - Director
The latest financial statements of Raunaq Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Raunaq Laboratories has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Raunaq Laboratories is U99999PB1994PLC014099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raunaq Laboratories was incorporated on 10 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chandigarh.
Jay Kothari ceased to be Additional Director on 30 Sep 2017. Jay Kothari was appointed as Director on 21 Apr 2017. Rajdeep Singh Thakur ceased to be Director on 21 Apr 2017. Raunaq Laboratories has 5 board changes on record in total.
The registered office of Raunaq Laboratories is at Wg 5541 Sony Nagarnakodar Road Jalandhar, Punjab, India.
Raunaq Laboratories operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Raunaq Laboratories is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.